TrialClinical and translational science2022

Effect of CSL112 (apolipoprotein A-I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross-study comparison.

Bo Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.